Home » Topics » BioWorld Science

BioWorld Science
RSS

Five-year D-CARE trial of denosumab in breast cancer misses primary endpoint

Feb. 2, 2018

Veliparib combined with oxaliplatin and capecitabine proven safe in solid cancers

Feb. 2, 2018

Affimed reveals new data from clinical studies of AFM-13

Feb. 2, 2018

Japanese submission seeks approval of Ventana OptiView ALK as companion diagnostic for Alecensa

Feb. 2, 2018

Roche presents new compounds for HBV

Feb. 2, 2018

Syndax and AstraZeneca to test durvalumab plus SNDX-6352 in solid tumors

Feb. 2, 2018

Crinetics Pharmaceuticals identifies new somatostatin SST2 receptor agonists

Feb. 2, 2018

Aduro BioTech and Novartis patent STING-agonists

Feb. 2, 2018

Phase II/III Japanese study of safinamide meets primary endpoint

Feb. 2, 2018

Medshine Discovery patents novel S1P1 agonists

Feb. 2, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 17, 2025
Clinical trial fraud ends with guilty pleas
BioWorld
In another real-life episode of “sponsor beware,” the owners of a clinical research facility pleaded guilty March 10 in U.S. district court to fraud charges...
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Hummingbird migrates ADCs, tech to newco Callio’s $187M debut
BioWorld
Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...